文献速递肿瘤 PET/CT神经核医学

联合68Ga-DOTATOC与18F-FDG PET预测多发性内分泌腺瘤1型患者胰腺神经内分泌肿瘤的双成分及不同分级

Combined 68Ga-DOTATOC and 18F-FDG PET Predicts a Double Component With Different Grade of a Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 1.
PubMed 文献 · Clin Nucl Med · 2020-01-01

一例31岁女性多发性内分泌腺瘤1型患者,疑似胰腺神经内分泌肿瘤,行68Ga-DOTATOC与18F-FDG PET检查。68Ga-DOTATOC在整肿瘤高摄取,18F-FDG仅肿瘤上部高摄取;术后病理证实肿瘤双成分:上部2级Ki67 11%对应高FDG摄取,下部1级Ki67 2%。联合68Ga-DOTATOC/18F-FDG PET可预测异质性胰腺神经内分泌肿瘤的分级。

要点

  • 联合68Ga-DOTATOC与18F-FDG PET可在术前提示胰腺神经内分泌肿瘤的异质性分级。
  • 18F-FDG高摄取区域对应Ki67 11%的2级成分,68Ga-DOTATOC高摄取覆盖全部肿瘤。

核心结论

  • 联合68Ga-DOTATOC/18F-FDG PET可预测异质性胰腺神经内分泌肿瘤的分级。

研究设计与样本

  • 本文为病例报告,对象为1例31岁女性多发性内分泌腺瘤1型患者,疑似胰腺神经内分泌肿瘤,行68Ga-DOTATOC与18F-FDG PET评估。

主要发现

  • 68Ga-DOTATOC在整肿瘤显示高摄取,而18F-FDG仅肿瘤上部显示高摄取。
  • 术后病理证实肿瘤为双成分:上部2级Ki67 11%对应高18F-FDG摄取,下部1级Ki67 2%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Managing decisions of pancreatic neuroendocrine tumors (pNETs) can be challenging because of different clinical presentations and prognosis. A 31-year-old woman with multiple endocrine neoplasia type 1, including a suspicious pNET, was assessed with Ga-DOTATOC and F-FDG PET. A high Ga-DOTATOC uptake was visualized in the entire pNET, whereas a high F-FDG PET uptake was present only in the upper part of the tumor. After surgery, pathology confirmed the pNET with a double component: an upper grade 2 with a Ki67 of 11% with the high F-FDG PET uptake, and a lower grade 1 with a Ki67 of 2%. Combined Ga-DOTATOC/F-FDG PET predicts the grade in heterogeneous pNETs.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Paepegaey AC, Gaujoux S, Meyer C, et al. Combined 68Ga-DOTATOC and 18F-FDG PET Predicts a Double Component With Different Grade of a Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 1. Clin Nucl Med. 2020. PMID: 32349092. doi:10.1097/RLU.0000000000003020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。